The synthetic TLR2 agonist BPPcysMPEG leads to efficient cross-priming against co-administered and linked antigens (Q43137532)

From Wikidata
Jump to navigation Jump to search
scientific article published in May 2010
edit
Language Label Description Also known as
English
The synthetic TLR2 agonist BPPcysMPEG leads to efficient cross-priming against co-administered and linked antigens
scientific article published in May 2010

    Statements

    The synthetic TLR2 agonist BPPcysMPEG leads to efficient cross-priming against co-administered and linked antigens (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit